• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2017

View Archived Issues

Bonti secures series B financing to support development of EB-001

Read More

Phase III trial studies Solucin for neuroendocrine tumors of gastroenteric or pancreatic origin

Read More

BAY-1895344: a potent candidate for DNA damage-related tumors

Read More

New phase III trial explores use of nintedanib in progressive fibrosing lung conditions

Read More

Abeome and CDC establish Zika collaboration

Read More

Parvus signs license and collaboration agreement with Novartis in type 1 diabetes

Read More

A-395 is a first-in-class antagonist of PRC2 protein-protein interactions

Read More

H3 Biomedicine identifies selective estrogen receptor covalent antagonist H3B-6545 for breast cancer

Read More

Results from the TRUE-AHF trial of ularitide in patients with acute heart failure

Read More

Bicycle reports preclinical milestone under ThromboGenics ophthalmology alliance

Read More

AbbVie initiates phase III study of ABT-494 for psoriatic arthritis

Read More

New chewable tablet formulation of Vyvanse available in U.S.

Read More

MedImmune begins first-in-human study of MEDI-5083 alone and with durvalumab in solid tumors

Read More

Phase I/IIa trial of FOL-005 demonstrates stimulation of hair growth in healthy volunteers

Read More

Vernalis and Servier patent DYRK1 and CLK1 inhibitors

Read More

Lion Biotechnologies and MD Anderson establish TIL therapy alliance

Read More

Oncochel Therapeutics identifies thiosemicarbazone iron chelators

Read More

Oragenics provides update regarding AG-013 and OG-716

Read More

Xenon Pharmaceuticals and Genentech present Nav1.7 channel blockers

Read More

Johnson & Johnson reports key milestones of first quarter 2017

Read More

Incyte discovers Pim kinases inhibitors

Read More

Zejula now available in U.S.

Read More

BioCryst Pharmaceuticals presents plasma kallikrein inhibitors

Read More

Qu Biologics reports response and remission rates from trial of Qbeco in Crohn's disease

Read More

PLx Pharma completes merger with Dipexium Pharmaceuticals

Read More

Phase III studies of veliparib in NSCLC and TNBC did not meet primary endpoints

Read More

Cancer Research UK, CPF and NCI collaborate to target RAS

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe